Literature DB >> 15995580

Phagocyte NADPH oxidase: a multicomponent enzyme essential for host defenses.

Jamel El-Benna1, Pham My-Chan Dang, Marie-Anne Gougerot-Pocidalo, Carole Elbim.   

Abstract

Phagocytes such as neutrophils and monocytes play an essential role in host defenses against microbial pathogens. Reactive oxygen species (ROS), such as superoxide anion, hydrogen peroxide, the hydroxyl radical, and hypochlorous acid, together with microbicidal peptides and proteases, constitute their antimicrobial arsenal. The enzyme responsible for superoxide anion production and, consequently, ROS generation, is called NADPH oxidase or respiratory burst oxidase. This multicomponent enzyme system is composed of cytosolic proteins (p47phox, p67phox, p40phox, and rac1/2) and membrane proteins (p22phox and gp91phox, which form cytochrome b558) which assemble at membrane sites upon cell activation. The importance of this enzyme in host defenses is illustrated by a life-threatening genetic disorder called chronic granulomatous disease in which the phagocyte enzyme is dysfunctional, leading to life-threatening bacterial and fungal infections. Also, because ROS can damage surrounding tissues, their production, and thus NADPH oxidase activation, must be tightly regulated. This review describes the structure and activation of the neutrophil NADPH enzyme complex.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15995580

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  52 in total

1.  Uveitis and a subretinal mass in a patient with chronic granulomatous disease.

Authors:  R R Buggage; R M Bauer; S M Holland; C I Santos; C-C Chan
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

Review 2.  Role of microglia in neuronal degeneration and regeneration.

Authors:  Lisa Walter; Harald Neumann
Journal:  Semin Immunopathol       Date:  2009-09-09       Impact factor: 9.623

3.  Luminol-amplified chemiluminescence detects mainly superoxide anion produced by human neutrophils.

Authors:  Samia Bedouhène; Farida Moulti-Mati; Margarita Hurtado-Nedelec; Pham My-Chan Dang; Jamel El-Benna
Journal:  Am J Blood Res       Date:  2017-07-25

Review 4.  Macrophage-mediated inflammation in metabolic disease.

Authors:  Ajay Chawla; Khoa D Nguyen; Y P Sharon Goh
Journal:  Nat Rev Immunol       Date:  2011-10-10       Impact factor: 53.106

5.  Ethanol preconditioning protects against ischemia/reperfusion-induced brain damage: role of NADPH oxidase-derived ROS.

Authors:  Qun Wang; Albert Y Sun; Agnes Simonyi; Theodore J Kalogeris; Dennis K Miller; Grace Y Sun; Ronald J Korthuis
Journal:  Free Radic Biol Med       Date:  2007-07-04       Impact factor: 7.376

Review 6.  Disifin (sodium tosylchloramide) and Toll-like receptors (TLRs): evolving importance in health and diseases.

Authors:  Okom Nkili F C Ofodile
Journal:  J Ind Microbiol Biotechnol       Date:  2007-09-05       Impact factor: 3.346

7.  Effects of Wy14643 on hepatic ischemia reperfusion injury in rats.

Authors:  Si-Qi Xu; Yuan-Hai Li; Sheng-Hong Hu; Ke Chen; Liu-Yi Dong
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

8.  Cooperative induction of CXCL10 involves NADPH oxidase: Implications for HIV dementia.

Authors:  Rachel Williams; Honghong Yao; Fuwang Peng; Yanjing Yang; Crystal Bethel-Brown; Shilpa Buch
Journal:  Glia       Date:  2010-04       Impact factor: 7.452

9.  Identification of potential pathway mediation targets in Toll-like receptor signaling.

Authors:  Fan Li; Ines Thiele; Neema Jamshidi; Bernhard Ø Palsson
Journal:  PLoS Comput Biol       Date:  2009-02-20       Impact factor: 4.475

10.  Punicic acid a conjugated linolenic acid inhibits TNFalpha-induced neutrophil hyperactivation and protects from experimental colon inflammation in rats.

Authors:  Tarek Boussetta; Houssam Raad; Philippe Lettéron; Marie-Anne Gougerot-Pocidalo; Jean-Claude Marie; Fathi Driss; Jamel El-Benna
Journal:  PLoS One       Date:  2009-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.